About TriSalus Life Sciences, Inc. 
TriSalus Life Sciences, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 12 Schemes (6.87%)
Foreign Institutions
Held by 12 Foreign Institutions (0.27%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
13 Million
(Quarterly Results - Dec 2025)
Net Profit:
-10 Million
Pharmaceuticals & Biotechnology
USD 253 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.38
136.48%
-9.45






